The Genitourinary Oncology Team in the Department of Medicine comprises medical oncologists, nurse practitioners/physician assistants and basic scientists. The group focuses on the use of novel agents in the treatment and prevention of genitourinary malignancies, and runs one of the largest Interleukin 2 (IL2) programs in the country. Prevention strategies involve a multidisciplinary team evaluating vitamin D both in the laboratory and clinically for prevention of prostate cancer. Treatment involves studies of novel agents in the therapy of prostate cancer and kidney cancer.
Institutionally, the GU team works in a multidisciplinary team of physicians and scientists from several medical fields: Epidemiology, Urology, Radiology, Radiation Oncology, and Pathology.